DA
DCF Advisers Portfolio holdings
AUM
$208M
1-Year Return
21.52%
This Quarter Return
-1.66%
1 Year Return
+21.52%
3 Year Return
+75.42%
5 Year Return
+129.34%
10 Year Return
–
AUM
$135M
AUM Growth
-$13.8M
(-9.2%)
Cap. Flow
-$6.29M
Cap. Flow
% of AUM
-4.64%
Top 10 Holdings %
Top 10 Hldgs %
51.3%
Holding
79
New
11
Increased
17
Reduced
17
Closed
11
Top Buys
| 1 |
AT&T
T
|
$1.53M |
| 2 |
Energy Transfer Partners
ET
|
$1.42M |
| 3 |
iShares MSCI China ETF
MCHI
|
$1.36M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
$1.25M |
| 5 |
Newmont
NEM
|
$841K |
Top Sells
| 1 |
SPDR S&P Oil & Gas Exploration & Production ETF
XOP
|
$2.09M |
| 2 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
$1.89M |
| 3 |
VanEck Junior Gold Miners ETF
GDXJ
|
$1.76M |
| 4 |
SPDR Gold Trust
GLD
|
$1.55M |
| 5 |
Altimmune
ALT
|
$1.36M |
Sector Composition
| 1 | Healthcare | 45.8% |
| 2 | Technology | 15.56% |
| 3 | Communication Services | 9.55% |
| 4 | Financials | 6.43% |
| 5 | Energy | 3.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
76
SPDR S&P Oil & Gas Exploration & Production ETF
XOP
$1.88B
| – | – |
-17,500
| Closed | -$2.09M |
|
|
RVNC
77
DELISTED
Revance Therapeutics, Inc.
RVNC
| – | – |
-12,000
| Closed | -$166K |
|
|
APTX
78
DELISTED
Aptinyx Inc. Common Stock
APTX
| – | – |
-48,529
| Closed | -$27K |
|